Literature DB >> 15788465

Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission.

Michael J Lim1, Canopy Roychoudhury, Patricia L Baker, Eduardo Bossone, Rajendra H Mehta.   

Abstract

OBJECTIVE: Several factors have been linked to the variation in the quality of care for patients with atrial fibrillation (AF). Whether hospitalization primarily for AF (primary diagnosis of AF) as opposed to another primary diagnosis but having concomitant AF (secondary diagnosis of AF) impacts quality of care for AF is not known. Accordingly, we sought to evaluate the differences in quality of care of Medicare patients admitted with primary diagnosis versus secondary diagnosis of AF. DESIGN AND
SETTING: We studied a random sample of Medicare fee-for-service discharges from Michigan's acute care hospitals over a 1-year period with a primary or secondary diagnosis of AF (ICD-9-CM 427.31). Main outcome measure. Warfarin use at the time of discharge.
RESULTS: Of 5993 patients in the study, 772 had a primary diagnosis of AF and 5221 had a secondary diagnosis of AF. Patients with a secondary diagnosis of AF were older, more likely to be male, and less likely to be hypertensive. Patients with a secondary diagnosis of AF 'ideal' for anticoagulation (n = 1648) were less likely to receive warfarin compared with 'ideal' patients with primary diagnosis of AF (n = 363) (52.6% versus. 59.8%, P < 0.001). Adherence to test indicators was lower in patients with secondary diagnosis of AF.
CONCLUSION: Secondary diagnosis of AF rather than AF as a primary diagnosis appears to account for most Medicare patients with AF admitted to hospitals. Whereas quality of care is lower in patients with secondary diagnosis of AF, opportunity for quality improvement exists for both groups of patients with AF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788465     DOI: 10.1093/intqhc/mzi026

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  3 in total

1.  Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.

Authors:  William R Lewis; Gregg C Fonarow; Kenneth A LaBresh; Christopher P Cannon; Wenqin Pan; Dennis M Super; Suzanne A Sorof; Lee H Schwamm
Journal:  Am J Cardiol       Date:  2008-11-07       Impact factor: 2.778

2.  Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.

Authors:  Prashant D Bhave; L Elizabeth Goldman; Eric Vittinghoff; Judith Maselli; Andrew Auerbach
Journal:  Am Heart J       Date:  2012-10-26       Impact factor: 4.749

Review 3.  Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis.

Authors:  Victoria L Baczek; Wendy T Chen; Jeffrey Kluger; Craig I Coleman
Journal:  BMC Fam Pract       Date:  2012-02-03       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.